Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Matuzalem.com-cz, s.r.o. | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Randomized, blinded vehicle-controlled multicenter clinical trial (MAT072017) to determine the effect of vaginal ovules containing 2 mg of the tea extract Matuzalem on the subjective symptoms (5-point scale pruritus (itching), dolor (pain), rubor (redness), fluor (discharge), and fetor (odor)), and objective symptoms (pH, Nugent score) of bacterial vaginosis. An ovule containing only the vehicle (polyethylene glycol 3000 S) was used as a control. The study was blinded from the perspective of the subject, investigator, laboratory personnel and data analyst.
The objective was to determine whether vaginal ovule with tea extract once-daily for 5-7 days improves symptoms of intermediate vaginal flora and prevents the development of bacterial vaginosis.
Composite primary endpoint designed as a drop in the Nugent score, vaginal pH, or improvement of subjective symptoms was compared between the active and vehicle (polyethylene-glycol) arm after 7 days of application and following 7 days after the application.
Secondary outcome measures were (1) Correction of the vaginal environment (as previously defined) 7 days after the completion of the prescribed 7-day regimen (day 14); (2) change in each parameter separately; (3) change in individual subjective symptoms, (4) exploratory analysis of the microbial environment at each subject visit.
The study was approved and supervised by the National authority and Ethics committee and prospectively registered in the Czech national medical device trial registry RZPRO and the European medical device trial registry EUDAMED.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Matuzalem | Experimental | Tea extract vaginal ovule daily for 7 consecutive days |
|
| Vehicle | Sham Comparator | Polyethylene glycol vaginal ovule daily for 7 consecutive days |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Matuzalem ovule | Device | vaginal ovule with 2 mg tea extract |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Composite endpoint (vaginal pH, Nugent score, subjective symptoms via questionnaire) after treatment completion | Correction of the vaginal environment after 7 days of once-daily application of the ovule was defined as: a drop-in Nugent score to < 4 and/or a drop in vaginal pH to < 4.5, or a subjective improvement in at least 2 symptoms by at least 2 points on a 5-point scale in patients whose baseline pH was < 4.5 and NS < 4. Subjective symptoms: Pruritus, dolor, rubor, fluor and fetor reported by the patient on 5-point scale (0=no problem to 4=severe problem) | following 7 days of the ovule daily application |
| Measure | Description | Time Frame |
|---|---|---|
| Composite endpoint (vaginal pH, Nugent score, subjective symptoms via questionnaire) after 7 days since treatment completion | Correction of the vaginal environment after 7 days after treatment completion defined as: a drop-in NS to < 4 and/or a drop in vaginal pH to < 4.5, or a subjective improvement in at least 2 symptoms by at least 2 points on a 5-point scale in patients whose baseline pH was < 4.5 and NS < 4. Subjective symptoms: Pruritus, dolor, rubor, fluor and fetor reported by the patient on 5-point scale (0=no problem to 4=severe problem) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tomáš Doležal, MD et PhD | Value Outcomes Ltd. | Study Director |
| Luboš Chadim, MVDr | Matuzalem.com-cz, s.r.o. | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centrum ambulantní gynekologie a primární péče, s.r.o. | Brno | Czech Republic | 60200 | Czechia | ||
| MUDr. Milan Kučera. s.r.o. |
Secondary analyses in progress
Not provided
Not provided
Not provided
Not provided
Not provided
vehicle-controlled two-arm
Not provided
Not provided
blinded from the perspective of the participant, investigator, laboratory analyst and data analyst
| Vehicle ovule |
| Device |
polyethylene glycol vaginal ovule |
|
| 7 days after the completion of the 7-day treatment |
| Change in the pH alone after treatment completion | Correction of the pH measured via pH strips | following 7 days of the ovule daily application |
| Change in the Nugent score alone after treatment completion | Nugent score determined under 1000x magnification | following 7 days of the ovule daily application |
| Change in the subjective symptoms (questionnaire) after treatment completion | Pruritus, dolor, rubor, fluor and fetor reported by the patient on 5-point scale (0=no problem to 4=severe problem) | following 7 days of the ovule daily application |
| Change in the pH alone after 7 days since treatment completion | Correction of the pH measured via pH strips | 7 days after the completion of the 7-day treatment |
| Change in the Nugent score alone 7 days after treatment completion | Nugent score determined under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Change in the subjective symptoms (questionnaire) 7 days after treatment completion | Pruritus, dolor, rubor, fluor and fetor reported by the patient on 5-point scale (0=no problem to 4=severe problem) | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: squamous epithelial cells | Quantification of: squamous epithelial cells under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: squamous epithelial cells | Quantification of: squamous epithelial cells under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: clue cells | Quantification of clue cells under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: clue cells | Quantification of clue cells under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: mixed flora | Quantification of mixed flora under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: mixed flora | Quantification of mixed flora under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: yeast as pseudomycelia | Quantification of yeast as pseudomycelia under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: yeast as pseudomycelia | Quantification of yeast as pseudomycelia under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: Gram negative diplococci | Quantification of: Gram negative diplococci under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: Gram negative diplococci | Quantification of: Gram negative diplococci under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: fibrous Lactobacillus | Quantification of: fibrous Lactobacillus under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: fibrous Lactobacillus | Quantification of: fibrous Lactobacillus under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: Gardnerella | Quantification of: Gardnerella under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: Gardnerella | Quantification of: Gardnerella under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: spirochetes | Quantification of: spirochetes under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: spirochetes | Quantification of: spirochetes under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: parabasal epithelial cells | Quantification of: parabasal epithelial cells under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: parabasal epithelial cells | Quantification of: parabasal epithelial cells under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: leukocytes | Quantification of: leukocytes under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: leukocytes | Quantification of: leukocytes under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: yeast as blastospores | Quantification of: yeast as blastospores under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: yeast as blastospores | Quantification of: yeast as blastospores under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: Gram pos. cocci in chains | Quantification of: Gram pos. cocci in chains under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: Gram pos. cocci in chains | Quantification of: Gram pos. cocci in chains under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: Lactobacillus | Quantification of: Lactobacillus under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: Lactobacillus | Quantification of: Lactobacillus under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: Mobilincus | Quantification of: Mobilincus under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: Mobilincus | Quantification of: Mobilincus under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: Leptotrichia | Quantification of: Leptotrichia under 1000x magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: Leptotrichia | Quantification of: Leptotrichia under 1000x magnification | 7 days after the completion of the 7-day treatment |
| Exploratory analysis of the microbial environment after treatment completion: Trichomonas vaginalis | Quantification of: Trichomonas vaginalis under 1000 magnification | following 7 days of the ovule daily application |
| Exploratory analysis of the microbial environment after 7 days after treatment completion: Trichomonas vaginalis | Quantification of: Trichomonas vaginalis under 1000 magnification | 7 days after the completion of the 7-day treatment |
| Kladno |
| Czech Republic |
| 27201 |
| Czechia |
| MUDr. Eva Novotná - FEMCARE s.r.o. | Odolena Voda | Czech Republic | 25070 | Czechia |
| OB/GYN Associates, s.r.o. | Prague | Czech Republic | 11000 | Czechia |
| MediStar s.r.o. | Prague | Czech Republic | 12000 | Czechia |
| MUDr. Michal Jelšík | Prague | Czech Republic | 12800 | Czechia |
| Gyn Por Ivf MUDr. Samer Asad s.r.o. | Prague | Czech Republic | 147000 | Czechia |
| Mediva s.r.o. | Prague | Czech Republic | 15500 | Czechia |
| GYNEKOLOGIE Studentský dům s.r.o. | Prague | Czech Republic | 16000 | Czechia |
| LEVRET s.r.o. | Prague | Czech Republic | 16000 | Czechia |
| T.B. Gyn s.r.o. | Prague | Czech Republic | 16100 | Czechia |
| Gynelav s.r.o. | Prague | Czech Republic | 16500 | Czechia |
| GYNEDAN s.r.o. | Prague | Czech Republic | Czechia |
| MUDr.Tereza Šmrhová-Kovács | Tábor | Czech Republic | 39003 | Czechia |
| ID | Term |
|---|---|
| D016585 | Vaginosis, Bacterial |
| ID | Term |
|---|---|
| D001424 | Bacterial Infections |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
| D014627 | Vaginitis |
| D014623 | Vaginal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
Not provided
Not provided